Medhus Bio, LLC. is developing following technologies:

Easy-Western

One step western-blot, dot-blot and immuno-blotting with color, fluorescent and luminescent options for detection.

GFIA Technology

A novel, patent-pending immuno-assay superior to traditional ELISA with the added convenience of a homogenous format.

Patent Pending

Multi-Cart

Multiplexed lateral-flow cartridges with chemi-luminescent detection for the diagnostic market.

3-D Bioreactor

A novel, patent-pending, turbulence-free bioreactor for stem cell growth and expansion.

Patent Pending

Assays for Stem Cell Differentiation

Novel biochemical assays for assessing stem cell differentiation into hepatocytes, cardiomyocytes, neuronal cells, hematopoietic cells and pancreatic B cells.

Interested in Our Technologies?

Contact us to learn more about licensing opportunities or collaborations

Get in Touch